Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

No abstract is available for this paper.

• Publication year

  2008

• Venue

  AIDS (London)

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QAD.0b013e3282fa75b9PMID 18580610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are Limited

  2007influential reference
• Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007–2008

  2007cited by this paper
• Drug resistance after failure of initial antiretroviral therapy in resource-limited countries.

  2007cited by this paper
• HIV viral load monitoring in resource-limited regions: optional or necessary?

  2007cited by this paper
• Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD)

  2007cited by this paper
• Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.

  2007cited by this paper
• Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens

  2007cited by this paper
• Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research

  2007cited by this paper
• When to switch for antiretroviral treatment failure in resource-limited settings?

  2007cited by this paper
• Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand.

  2007cited by this paper
• A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.

  2006cited by this paper
• Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

  2006cited by this paper
• Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

  2006cited by this paper
• The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund.

  2006cited by this paper
• Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort

  2006cited by this paper
• Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.

  2005cited by this paper
• Clinical outcome after 4 years follow‐up of HIV‐seropositive subjects with incomplete virologic or immunologic response to HAART

  2005cited by this paper
• Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.

  2004cited by this paper
• Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.

  2004cited by this paper
• Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

  2002cited by this paper
• The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

  2001cited by this paper

• Second-Line Antiretroviral Treatment Outcomes and Predictors in Tigray Region, Ethiopia

  2023cites this paper
• Risk Factors for Viral Non-Suppression among People Living with HIV and Major Depressive Disorder in Uganda

  2022cites this paper
• Treatment failure, death, and predictors among PLWHIV on second-line antiretroviral therapy in Dessie Comprehensive Specialized Hospital, northeast Ethiopia: A retrospective cohort study

  2022cites this paper
• Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy

  2021cites this paper
• Predictive Factors of High-Risk Events for Virological Failure in HIV/AIDS Patients Receiving Long-Term Antiviral Therapy

  2021cites this paper
• Immunologic and Clinical Failure of Antiretroviral Therapy in People Living with Human Immunodeficiency Virus within Two Years of Treatment

  2020cites this paper
• Study of atazanavir-induced hyperbilirubinemia among HIV patients on second-line anti-retroviral therapy

  2020influential citation
• INCIDENCE OF SWITCHING TO SECOND LINE TREATMENT AMONG HIV PATIENTS RECEIVING ANTI-RETROVIRAL THERAPY

  2020cites this paper
• Study of Immunological and Virological Recovery in HIV/AIDS Patients on Second Line Anti-Retroviral Therapy: A Prospective Study

  2020cites this paper
• Resistance Profile of Human Immunodeficiency Virus 1 (HIV-1) Quasispecies in Patients Under Treatment Failure Using Single Molecule, Real-Time (SMRT) Sequencing.

  2020cites this paper
• Virological outcomes of second-line antiretroviral therapy for HIV-1 patients in center of excellence, Gandhi Hospital, Secundrabad, Telangana

  2019cites this paper
• Six-Year Immunologic Recovery and Virological Suppression of HIV Patients on LPV/r-Based Second-Line Antiretroviral Treatment: A Multi-Center Real-World Cohort Study in China

  2019cites this paper
• ART Regimen and Other Sociodemographics Do Not Affect Cytokine Expression in HIV Patients in Ghana

  2019cites this paper
• Moderate incidence of lost follow-up and risk factors among adult HIV patients on second-line ART regimens in Amhara region hospitals, Ethiopia

  2019cites this paper
• Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy–evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011

  2018cites this paper
• A Prospective Study to Evaluate Prescription Pattern of Second Line Antiretroviral Therapy Given to HIV Patients

  2018cites this paper
• Immunological failure in HIV-infected adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study

  2018cites this paper
• Treatment Outcome of Second Line Anti-retroviral Therapy in HIV Positive Patients Over One Year Period

  2018cites this paper
• Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015

  2017cites this paper
• Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis.

  2017cites this paper
• Boosted-lopinavir versus boosted-atazanavir plus two nucleoside reverse transcriptase inhibitors in second-line antiretroviral therapy in HIV-1 infected patients in Abidjan , Ivory Coast

  2017cites this paper
• Assessing the Efficacy of Second-Line Antiretroviral Treatment for HIV Patients Failing First-Line Antiretroviral Therapy in Iran: A Cohort Study.

  2017cites this paper
• Comparative study of adverse effect profile of first line drugs Zidovudine (ZDV) + Lamivudine (3TC) + Nevirapine (NVP) Vs Tenofovir (TDF) + Lamivudine (3TC) + Atazanavir (ATV) + Ritonovir (RTV) in HIV/AIDS patients

  2017cites this paper
• First Antiretroviral Therapy Changes in People Living with HIV in Senegal:Incidence, Causes and Predictive Factors

  2017cites this paper
• Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa

  2017cites this paper
• Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar

  2017cites this paper
• Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort

  2017cites this paper
• Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm

  2016cites this paper
• On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings

  2016cites this paper
• Eastern Caribbean Physicians’ Responses to Providing HIV/AIDS Care in Resource-Limited Settings

  2016cites this paper
• Clinical, Immunological and Virological Profile of Patients with HIV Infection on Second Line Antiretroviral Therapy

  2016cites this paper
• Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification

  2016cites this paper
• The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania

  2016influential citation
• Profile of HIV Patients on Second Line Antiretroviral Therapy: The Indian Experience

  2015cites this paper
• Lack of awareness of treatment failure among HIV-1-infected patients in Guinea-Bissau – a retrospective cohort study

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Prevalence and Predictors of Immunological Failure among HIV Patients on HAART in Southern Ethiopia

  2015cites this paper
• Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study

  2015cites this paper
• Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.

  2015cites this paper
• Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.

  2015cites this paper
• Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria

  2015cites this paper
• Second line Antiretroviral Treatment failure and predictors among adults in northwest Ethiopia

  2015cites this paper
• Optimizing HIV Therapy: outcomes, challenges, and opportunities for virological monitoring in resource-limited settings

  2015influential citation
• Filename Chapter 10: Second-line antiretroviral treatment successfully resuppresses drug resistant HIV-1 after first-line failure: prospective cohort in sub-

  2015cites this paper
• Loss to follow-up from South Africa's antiretroviral treatment programme: Trends, risk factors, and models of care to improve retention

  2015cites this paper
• Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa: A Model-Based Analysis in Côte d'Ivoire

  2014cites this paper
• Bases moléculaires de la résistance des VIH-1 de sous-types non B aux nouveaux antirétroviraux

  2014cites this paper
• Incidences and risk factors of first-line HAART discontinuation: a limitation to the success of the “seek, test, treat, and retain” strategy?

  2014cites this paper
• Equity in access to HIV/AIDS services in Zambia : the role of social cohesion in HIV prevention and care

  2014cites this paper
• Predictor Factors for Treatment Failure among Patients on Second Line Antiretroviral Therapy

  2014cites this paper
• Second-line antiretroviral therapy in northern Tanzania

  2014influential citation
• Virological failure among adult HIV positive patients three years after starting antiretroviral treatment at Mankweng Hospital, Limpopo Province, RSA

  2014cites this paper
• Treatment Effect and Drug-Resistant Mutations in Chinese AIDS Patients Switching to Second-Line Antiretroviral Therapy

  2014cites this paper
• Long-Term Outcome of Second-Line Antiretroviral Therapy in Resource-Limited Settings

  2014cites this paper
• Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia

  2014cites this paper
• Association of First-Line and Second-Line Antiretroviral Therapy Adherence

  2014cites this paper
• What to do Next? Second-line Antiretroviral Therapy

  2014cites this paper
• Outcomes of Antiretroviral Therapy Over a 10-Year Period of Expansion: A Multicohort Analysis of African and Asian HIV Programs

  2014cites this paper
• HIV drug resistance among adults and children in sub-Saharan Africa

  2013cites this paper
• Second-Line Protease Inhibitor-Based Haart after Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens in Asian HIV-Infected Children

  2013cites this paper
• Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients

  2013cites this paper
• Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa — A Systematic Review and Meta-Analysis

  2013influential citation
• Profile of HIV-infected patients receiving second-line antiretroviral therapy in a resource-limited setting in Nigeria.

  2013cites this paper
• igh rate of virologic suppression with darunavir / ritonavir lus optimized background therapy among highly ntiretroviral-experienced HIV-infected patients : results of a rospective cohort study in São Paulo , Brazil

  2013influential citation
• EVOLUTION OF PATIENTS WITH AIDS AFTER cART: CLINICAL AND LABORATORY EVOLUTION OF PATIENTS WITH AIDS AFTER 48 WEEKS OF ANTIRETROVIRAL TREATMENT

  2013cites this paper
• Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy

  2013cites this paper
• Male, Mobile, and Moneyed: Loss to Follow-up in an Urban African Antiretroviral Treatment Clinic

  2013cites this paper
• Treatment outcomes of second line antiretroviral therapy in Mbagathi district hospital comprehensive care clinic

  2013influential citation
• Drug-resistant HIV-1 in sub-Saharan Africa: clinical and public health studies

  2013cites this paper
• Managing HIV treatment in resource-limited and dynamic environments

  2013cites this paper
• Optimizing Treatment Switch for Virologic Failure during First-Line Antiretroviral Therapy in Resource-Limited Settings

  2013cites this paper
• Second-Line Protease Inhibitor-Based Antiretroviral Therapy after Non-Nucleoside Reverse Transcriptase Inhibitor Failure: The Effect of a Nucleoside Backbone

  2013cites this paper
• High rate of virologic suppression with darunavir/ritonavir plus optimized background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil

  2013influential citation
• Recent Developments in Hiv Treatment and Their Dissemination in Poor Countries

  2013cites this paper
• Male, Mobile, and Moneyed: Loss to Follow-Up vs. Transfer of Care in an Urban African Antiretroviral Treatment Clinic

  2013cites this paper
• failure: prospective cohort in sub-Saharan Africa

  2012cites this paper
• Gender Differences in Immune Reconstitution: A Multicentric Cohort Analysis in Sub-Saharan Africa

  2012cites this paper
• Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.

  2012cites this paper
• Utilisation du modèle CEPAC en appui à la recherche clinique dans le domaine de la prise en charge des adultes infectés par le VIH en Afrique sub-saharienne

  2012cites this paper
• Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009

  2012cites this paper
• Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community

  2012cites this paper
• Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

  2012cites this paper
• Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings

  2012cites this paper
• Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa

  2012cites this paper
• Second-Line Antiretroviral Therapy in a Workplace and Community-Based Treatment Programme in South Africa: Determinants of Virological Outcome

  2012influential citation
• Tuberculosis and HIV Co-Infection

  2011cites this paper
• Outcomes of antiretroviral treatment program in Ethiopia: Retention of patients in care is a major challenge and varies across health facilities

  2011cites this paper
• Switch to second-line ART in West African routine care: incidence and reasons for switching

  2011cites this paper
• High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia

  2011cites this paper
• Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020

  2011cites this paper
• Virologic and Immunologic Outcomes of the Second-Line Regimens of Antiretroviral Therapy Among HIV-Infected Patients in Thailand

  2011cites this paper
• Early Outcomes and the Virological Effect of Delayed Treatment Switching to Second-Line Therapy in An Antiretroviral Roll-Out Programme in South Africa

  2011cites this paper
• Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings

  2011cites this paper
• Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India

  2011cites this paper
• Treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource‐limited settings

  2011cites this paper
• Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa

  2011cites this paper
• Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients

  2011cites this paper
• ‘Getting to Zero’: a steep path ahead

  2011cites this paper
• A follow-up study of HIV-infected adults in rural Tanzania after antiretroviral treatment failure

  2011cites this paper
• Adverse effects on second-line highly active antiretroviral therapy (HAART) among HIV infected adults and children treated at Mildway Uganda

  2011cites this paper